AB
PCVX icon

Amalgamated Bank’s Vaxcyte PCVX Stock Holding History

Amalgamated Bank’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Sell
3,576
-21
-0.6% -$1.14K ﹤0.01% 1583
2026
Q1 		$209K Hold
3,597
– – ﹤0.01% 1546
2025
Q4 		$166K Sell
3,597
-112
-3% -$5.01K ﹤0.01% 1604
2025
Q3 		$134K Sell
3,709
-592
-14% -$19.6K ﹤0.01% 1651
2025
Q2 		$140K Hold
4,301
– – ﹤0.01% 1640
2025
Q1 		$162K Buy
4,301
+220
+5% +$17.6K ﹤0.01% 1580
2024
Q4 		$334K Hold
4,081
– – ﹤0.01% 1432
2024
Q3 		$466K Buy
4,081
+322
+9% +$29K ﹤0.01% 1328
2024
Q2 		$284K Buy
3,759
+150
+4% +$10.2K ﹤0.01% 1485
2024
Q1 		$247K Sell
3,609
-9,801
-73% -$679K ﹤0.01% 1540
2023
Q4 		$842K Sell
13,410
-688
-5% -$35.7K 0.01% 1229
2023
Q3 		$719K Buy
14,098
+785
+6% +$38.7K 0.01% 1257
2023
Q2 		$665K Buy
13,313
+3,140
+31% +$149K 0.01% 1297
2023
Q1 		$381K Sell
10,173
-1,684
-14% -$71.4K ﹤0.01% 1542
2022
Q4 		$569K Buy
11,857
+3,263
+38% +$128K 0.01% 1410
2022
Q3 		$206K Buy
8,594
+267
+3% +$6.77K ﹤0.01% 1834
2022
Q2 		$181K Buy
8,327
+2,970
+55% +$68.7K ﹤0.01% 1912
2022
Q1 		$129K Buy
+5,357
New +$117K ﹤0.01% 2103

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Amalgamated Bank's PCVX Position: Q2 2026 in Review

Amalgamated Bank reduced its Vaxcyte (PCVX) stake by 0.58% in Q2 2026, selling an estimated $1.14K and leaving 3,576 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

Amalgamated Bank first reported a position in PCVX in Q1 2022 and has held it in 18 quarters since. The position peaked at $842K in Q4 2023. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Amalgamated Bank held 3,576 shares of Vaxcyte worth $208K as of Q2 2026.
  • Amalgamated Bank sold 21 Vaxcyte shares in Q2 2026, an estimated $1.14K.
  • Vaxcyte made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1583 holding.
  • Amalgamated Bank first reported a position in Vaxcyte in Q1 2022 and has held it in 18 quarters since.
  • Amalgamated Bank's Vaxcyte position peaked at $842K in Q4 2023.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.